Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other 1Gynecologic 1Breast 1

Conditions

Sedentary Behavior 2Obesity 1Endometrial Neoplasms 1Breast Neoplasms 1

Interventions

Cyclophosphamide 3162Cisplatin 3160Carboplatin 2938Paclitaxel 2673Radiotherapy 2648Gemcitabine 2547pembrolizumab 2331Docetaxel 2157Bevacizumab 2128Fluorouracil 1822Capecitabine 1784Oxaliplatin 1713Dexamethasone 1590Nivolumab 1517Doxorubicin 1477Rituximab 1454Etoposide 1342Magnetic Resonance Spectroscopy 1266Irinotecan 1235Leucovorin 1216Cytarabine 1123Pemetrexed 1062Drug Therapy 1062fludarabine 1050Vincristine 956Specimen Handling 936Prednisone 926Cetuximab 921Lenalidomide 916Trastuzumab 902

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Blood Glucose Self-Monitoring × Clear all
NCT05409664 2025-05-15

MFT4

University of South Carolina

Phase NA Active not recruiting
68 enrolled
Breast

Breast Neoplasms, Sedentary Behavior

NCT05737745 2025-05-09

FitEx for Endometrial Cancer Survivors: Initial Efficacy

Carilion Clinic

Phase NA Completed
111 enrolled 7 charts
GynecologicOther

Obesity, Endometrial Neoplasms, Sedentary Behavior

Data powered by HemOnc (CC BY 4.0) Colophon âš¡